TMDX Earnings
Latest Revenue189.9M
Latest Net Income14.7M
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q2 2026 | $0.42 | 189.9M | 14.7M | +20.7% | -59.2% |
| Q1 2026 | $0.21 | 173.9M | 7.3M | +21.2% | -72.4% |
| Q4 2025 | $3.08 | 160.8M | 105.4M | +32.2% | +1,440.0% |
| Q3 2025 | $0.71 | 143.8M | 24.3M | +32.2% | +446.2% |
| Q2 2025 | $1.03 | 157.4M | 34.9M | +37.7% | +178.4% |
| Q1 2025 | $0.76 | 143.5M | 25.7M | +48.2% | +105.4% |
| Q4 2024 | $0.20 | 121.6M | 6.9M | +49.8% | +66.7% |
| Q3 2024 | $0.13 | 108.8M | 4.2M | +63.7% | +116.7% |
| Q2 2024 | $0.37 | 114.3M | 12.2M | — | — |
| Q1 2024 | $0.37 | 96.8M | 12.2M | — | — |
| Q4 2023 | $0.12 | 81.2M | 4.0M | — | — |
| Q3 2023 | -$0.78 | 66.4M | -25422000 | — | — |
TransMedics (TMDX) — Earnings